Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Prostate cancer | R-HSA-2990872 | map05215 | amoxapine | 2170 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | amoxapine | 2170 | drug-path |
Acute myeloid leukemia | R-HSA-9680350 | map05221 | amoxapine | 2170 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | amoxapine | 2170 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | amoxapine | 2170 | drug-path |
ErbB signaling pathway | R-HSA-168638 | map04012 | amoxapine | 2170 | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | amoxapine | 2170 | drug-path |
Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | amoxapine | 2170 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | amoxapine | 2170 | drug-path |
Type II diabetes mellitus | R-HSA-2127377 | map04930 | amoxapine | 2170 | drug-path |
Endometrial cancer | R-HSA-2077421 | map05213 | amoxapine | 2170 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | amoxapine | 2170 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | amoxapine | 2170 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | amoxapine | 2170 | drug-path |
Glioma | Q9NZM4 | map05214 | zimeldine | 5311054 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | zimeldine | 5311054 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | zimeldine | 5311054 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | zimeldine | 5311054 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | zimeldine | 5311054 | drug-path |
Shigellosis | 0 | map05131 | zimeldine | 5311054 | drug-path |